MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

20th International Congress » Parkinson's disease: Psychiatric manifestations

Date: Wednesday, June 22, 2016

Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Session Type: Poster Session

Meeting: 20th International Congress

12:00pm-1:30pm
Affective theory of mind in Parkinson’s disease

A.M. Hammad, S. Ghozy, S.I. El-Jaafary (Cairo, Egypt)

12:00pm-1:30pm
Anhedonia and its correlation with clinical aspects in Parkinson’s disease

H. Nagayama (Tokyo, Japan)

12:00pm-1:30pm
Anxiety and parkinsonism signs in idiopathic REM sleep behavior disorder

F. Escudier, R.B. Postuma, P.A. Bourgouin, J. Montplaisir, J.F. Gagnon (Montreal, QC, Canada)

12:00pm-1:30pm
Bradykinesia, low monthly income and current employment are associated with depression in patients with Parkinson’s disease: Results of a study from Sri Lanka

M.R. Withana, T.B. Herath, C. Rodrigo, C. Gamage, R. Gamage (Colombo, Sri Lanka)

12:00pm-1:30pm
Cognitive and behavioral side effects in patients treated with droxidopa for neurogenic orthostatic hypotension

K.E. McDonell, C.A. Shibao, I. Biagginoi, D. Robertson, D.O. Claassen (Nashville, TN, USA)

12:00pm-1:30pm
Cognitive function and self-reported depressive symptoms in a population-based cohort to study non-motor-symptoms of Parkinson’s disease

E.J. Vollstedt, K. Hückelheim, S. Tunc, J. Hampf, C. Kritzinger, M. Kasten, C. Klein (Luebeck, Germany)

12:00pm-1:30pm
Coping styles and their influence on outcomes in Parkinson’s disease

K.M. Sundvick, F. Kassam, N. Dispirito, E. Book, S. Cresswell (Vancovuer, BC, Canada)

12:00pm-1:30pm
Dementia in Parkinson’s disease: Is male gender a risk factor?

E. Cereda, R. Cilia, C. Klersy, C. Siri, A. Colombo, B. Pozzi, E. Reali, A.L. Zecchinelli, C.B. Mariani, S. Tesei, M. Canesi, G. Sacilotto, N. Meucci, M. Zini, I.U. Isaias, M. Barichella, E. Cassani, S. Glodwurm, G. Pezzoli (Pavia, Italy)

12:00pm-1:30pm
Disease-related variables effect on depression and anxiety level in Parkinson’s patients

T. Uyar, D. Sarikaya Varlik, A. Ercan, O.C. Cenker, I. Gungor Dogan (Rize, Turkey)

12:00pm-1:30pm
EARLYSTIM: STN-DBS alleviates behavioural side effects of dopamine replacement therapy when compared to best medical treatment

E. Lhommée, W. Lars, C. Virginie, K. Witt, F. Maier, L. Tonder, L. Timmermann, T. Hälbig, F. Pineau, F. Durif, T. Witjas, J.L. Houeto, P. Krack (Grenoble, France)

12:00pm-1:30pm
Effectiveness of duodenal levodopa/carbidopa infusion gel (LCIG) therapy on the neuropsychiatric disturbances of advanced Parkinson’s disease (EDIS study)

M.J. Catalan, P. Montero, J. Herreros, J.M. Arbelo, P. Martinez-Martin (Madrid, Spain)

12:00pm-1:30pm
Facial expressivity in Parkinson’s disease (PD) via an examination of smiling behavior: Preliminary findings

D.L. McCabe, A.D. Bono, R.J. Stafford, A.I. Dumer, K.A. Scorpio, J.L. Spielman, R. Bind, L.O. Ramig, J.C. Borod (New York, NY, USA)

12:00pm-1:30pm
Factors related to psychotic symptoms in patients with Parkinson’s disease

B. Tserensodnom (Ulaanbaatar, Mongolia)

12:00pm-1:30pm
Feasibility and effectiveness of a low-threshold psychoeducative group-intervention for depression in Parkinson’s disease

K. Linse, M. Fauser, C. Ossig, A. Hermann, A. Storch (Dresden, Germany)

12:00pm-1:30pm
Fractionating apathy – Effort, reward and impulsivity mechanisms in Parkinson’s and Huntington’s disease

C. O'Callaghan, S. Mason, C. Williams-Gray, R. Barker, B. Sahakian, T. Robbins (Cambridge, United Kingdom)

12:00pm-1:30pm
Illusional perception in Parkinson’s disease

C. Ding, C. Palmer, J. Hohwy, G. Youssef, B. Paton, N. Tsuchiya, J. Stout, D. Thyagarajan (Clayton, Australia)

12:00pm-1:30pm
Impulse control disorder in early Parkinson’s disease: Follow-up study

V. Markovic, I. Stankovic, I. Petrovic, T. Stojkovic, M. Jecmenica-Lukic, A. Tomic, V. Kostic (Belgrade, Serbia)

12:00pm-1:30pm
Impulse control disorder in Parkinson’s disease is not related to lower cognitive performance

J. Marin-Lahoz, R. Fernandez-Bobadilla, J. Pagonabarraga, S. Martinez-Horta, B. Pascual-Sedano, J. Perez-Perez, H. Bejr-Kasem, A. Gironell, J. Kulisevsky (Barcelona, Spain)

12:00pm-1:30pm
Neuroanatomical correlates of apathy in non-demented and non-depressed Parkinson’s disease

S. Martinez-Horta, F. Sampedro, J. Pagonabarraga, R. Fernandez-Bobadilla, J. Marin-Lahoz, J. Kulisevsky (Barcelona, Spain)

12:00pm-1:30pm
Neuroleptic medication is associated with a worse health status in the years prior to treatment, but have the potential for normalization

P. Schmidt, F. Cubillos, T. Simuni, C. Marras, T. Davis, E.C. Nelson, M.S. Okun (Miami, FL, USA)

12:00pm-1:30pm
Neuropsychiatric, personality and non-motor correlates of impulse control disorders in recent onset Parkinson’s disease

D.M.A. Swallow, M.A. Lawton, K.A. Grosset, N. Malek, N. Bajaj, R.A. Barker, Y. Ben-Shlomo, D.J. Burn, T. Foltynie, J. Hardy, H.R. Morris, N. Williams, N.W. Wood, D.G. Grosset, PRoBaND Collaborators (Glasgow, United Kingdom)

12:00pm-1:30pm
Neuropsychological correlates of impulse control disorders and punding in Parkinson´ s disease

G. Santangelo, F. Falco, M. Vicidomini, R. Allocca, P. Barone, C. Vitale (Caserta, Italy)

12:00pm-1:30pm
Parkinson’s disease associated psychosis: Prevalence and risk factors

A. Dutt, H. Kumar, M. Mukherjee, M.U. Kulsum, C. Sengupta (Kolkata, India)

12:00pm-1:30pm
Phenotypic spectrum and longitudinal outcome of Parkinson’s disease patients with psychosis

M.S. Nanjunda Swamy, M.M. Abbas, S.T. Govindappa, P. Basu, R. Ramanathan, U.B. Muthane (Bangalore, India)

12:00pm-1:30pm
Prevalence of depression in Parkinson’s disease patients

A.M. Weldehana (Addis Ababa, Ethiopia)

12:00pm-1:30pm
Prevalence of impulse control disorders among adult Filipino patients with idiopathic Parkinson’s disease seen at a tertiary center in Manila

J.K.P. de Guzman, A.D. Yap, C.L. Go (Manila, Philippines)

12:00pm-1:30pm
Profile of depressive symptoms in Parkinson’s disease patients and a population-based elderly cohort

K. Hückelheim, E.J. Vollstedt, S. Tunc, J. Hampf, J. Graf, V. Tadic, C. Klein, M. Kasten (Lübeck, Germany)

12:00pm-1:30pm
Psychiatric manifestations in the initial motor stage of Parkinson’s disease

I. Stankovic, E. Stefanova, A. Tomic, M. Jecmenica Lukic, V. Markovic, N. Kresojevic, I. Petrovic, M. Svetel, V.S. Kostic (Belgrade, Serbia)

12:00pm-1:30pm
Relation between personality trait and depression in Parkinson’s disease

A. Kumon, Y. Kobayashi, M. Saruwatari, N. Kawashima, K. Hasegawa (Sagamihara, Japan)

12:00pm-1:30pm
Reward insensitivity differentiates apathy from depression in Parkinson’s disease

K. Muhammed, M. Ben Yehuda, D. Drew, S. Manohar, T. Chong, G. Tofaris, M. Bogdanovic, G. Lennox, M. Hu, M. Husain (Oxford, United Kingdom)

12:00pm-1:30pm
Screening for neuropsychiatric symptoms in Parkinson’s disease

M.J. Barrett, S.A. Sperling, B.B. Shah, J.L. Flanigan, G.F. Wooten, M.B. Harrison, C.A. Manning (Charlottesville, VA, USA)

12:00pm-1:30pm
Subthalamic neurons encode reward hypersensitivity and loss hyposensitivity in Parkinson’s patients with impulse control disorders

P.J. Rossi, A. Gunduz, M.S. Okun (Gainesville, FL, USA)

12:00pm-1:30pm
Technology use and impulse control disorders (ICDs) in patients with Parkinson’s disease (PD)

E.A. Byrd, C.M. Tanner, C.A. Racine, N.B. Galifianakis (San Francisco, CA, USA)

12:00pm-1:30pm
The cerebral structural and functional signatures of impulse control disorder in Parkinson’s disease

F. Imperiale, F. Agosta, E. Canu, V. Špica, M. Jecmenica, M. Copetti, V.S. Kostic, M. Filippi (Milan, Italy)

12:00pm-1:30pm
The role of depression in suicidal ideation in a sample of patients with Parkinson’s disease

M.M. Dumitru (Iasi, Romania)

12:00pm-1:30pm
Viewer responses to a virtual reality simulation of Parkinson’s disease psychosis

J.G. Goldman, G.T. Stebbins, D. Fredericks, M. Upchurch (Chicago, IL, USA)

12:00pm-1:30pm
Visual hallucinations and executive dysfunction in Charles Bonnet syndrome: Preliminary findings from SHAPED

D.H. Ffytche, F. D'Antonio, R. Pinto, D. Collerton, J.P. Taylor, D.J. Burn, R. Barker, D. Aarsland, R. Howard (London, United Kingdom)

12:00pm-1:30pm
Volition and action control in Parkinson’s disease patients with impulsive-compulsive behaviour disorders

L. Ricciardi, P. Haggard, L. de Boer, C. Sorbera, M.P. Stenner, F. Morgante, M.J. Edwards (London, United Kingdom)

« View all sessions from the 20th International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley